Xili Chu

1.1k total citations
21 papers, 889 citations indexed

About

Xili Chu is a scholar working on Molecular Biology, Biochemistry and Cancer Research. According to data from OpenAlex, Xili Chu has authored 21 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Biochemistry and 5 papers in Cancer Research. Recurrent topics in Xili Chu's work include Extracellular vesicles in disease (8 papers), MicroRNA in disease regulation (5 papers) and Sulfur Compounds in Biology (5 papers). Xili Chu is often cited by papers focused on Extracellular vesicles in disease (8 papers), MicroRNA in disease regulation (5 papers) and Sulfur Compounds in Biology (5 papers). Xili Chu collaborates with scholars based in China, Thailand and Austria. Xili Chu's co-authors include Zhen Wang, Danqing Xin, Dexiang Liu, Xin Zhou, Tingting Li, Hongfei Ke, Tingting Li, Hongtao Yuan, Hao Xue and Jie Qiu and has published in prestigious journals such as Cell Metabolism, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

Xili Chu

21 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xili Chu China 15 545 238 140 129 118 21 889
Danqing Xin China 21 705 1.3× 289 1.2× 191 1.4× 154 1.2× 124 1.1× 36 1.2k
Takeru Hamashima Japan 16 429 0.8× 148 0.6× 209 1.5× 77 0.6× 105 0.9× 37 995
Oneil G. Bhalala Australia 9 470 0.9× 281 1.2× 64 0.5× 61 0.5× 42 0.4× 18 955
Yanjie Jia China 20 644 1.2× 326 1.4× 145 1.0× 179 1.4× 63 0.5× 76 1.2k
Kai Gao China 21 722 1.3× 354 1.5× 91 0.7× 120 0.9× 55 0.5× 67 1.3k
Xiaoming Che China 16 500 0.9× 137 0.6× 289 2.1× 142 1.1× 137 1.2× 43 1.2k
Tanya L. Butler Australia 17 517 0.9× 86 0.4× 272 1.9× 198 1.5× 135 1.1× 25 1.1k
Chengcheng Cui China 13 495 0.9× 251 1.1× 223 1.6× 58 0.4× 62 0.5× 21 870
Yuhong Zhu China 12 356 0.7× 138 0.6× 164 1.2× 42 0.3× 88 0.7× 18 824
Hsin-I Ma Taiwan 22 488 0.9× 198 0.8× 59 0.4× 131 1.0× 52 0.4× 37 1.0k

Countries citing papers authored by Xili Chu

Since Specialization
Citations

This map shows the geographic impact of Xili Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xili Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xili Chu more than expected).

Fields of papers citing papers by Xili Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xili Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xili Chu. The network helps show where Xili Chu may publish in the future.

Co-authorship network of co-authors of Xili Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Xili Chu. A scholar is included among the top collaborators of Xili Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xili Chu. Xili Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Cheng, Hongming Ma, Shuai Wu, et al.. (2024). Secreted PTEN binds PLXDC2 on macrophages to drive antitumor immunity and tumor suppression. Developmental Cell. 59(23). 3072–3088.e8. 13 indexed citations
2.
Ge, Meng-Kai, Cheng Zhang, Na Zhang, et al.. (2023). The tRNA-GCN2-FBXO22-axis-mediated mTOR ubiquitination senses amino acid insufficiency. Cell Metabolism. 35(12). 2216–2230.e8. 33 indexed citations
3.
Gao, Yifei, Yan Tang, Haojie Zhang, et al.. (2021). Vincristine leads to colonic myenteric neurons injury via pro-inflammatory macrophages activation. Biochemical Pharmacology. 186. 114479–114479. 13 indexed citations
4.
Li, Tingting, Danqing Xin, Hongfei Ke, et al.. (2021). L-Cysteine attenuates osteopontin-mediated neuroinflammation following hypoxia-ischemia insult in neonatal mice by inducing S-sulfhydration of Stat3. Acta Pharmacologica Sinica. 43(7). 1658–1669. 10 indexed citations
5.
Yin, Sen, Xuemei Bai, Danqing Xin, et al.. (2020). Neuroprotective Effects of the Sonic Hedgehog Signaling Pathway in Ischemic Injury through Promotion of Synaptic and Neuronal Health. Neural Plasticity. 2020. 1–11. 23 indexed citations
6.
Han, Min, Ying Cao, Xiaofan Guo, et al.. (2020). Mesenchymal stem cell-derived extracellular vesicles promote microglial M2 polarization after subarachnoid hemorrhage in rats and involve the AMPK/NF-κB signaling pathway. Biomedicine & Pharmacotherapy. 133. 111048–111048. 48 indexed citations
7.
Ke, Hongfei, Dexiang Liu, Tingting Li, et al.. (2020). <p>Hydrogen-Rich Saline Regulates Microglial Phagocytosis and Restores Behavioral Deficits Following Hypoxia-Ischemia Injury in Neonatal Mice via the Akt Pathway</p>. Drug Design Development and Therapy. Volume 14. 3827–3839. 8 indexed citations
8.
Li, Gang, Zhen Wang, Ye Xiong, et al.. (2020). Neuroprotective mechanism of L-cysteine after subarachnoid hemorrhage. Neural Regeneration Research. 15(10). 1920–1920. 9 indexed citations
9.
Xin, Danqing, Tingting Li, Xili Chu, et al.. (2020). MSCs-extracellular vesicles attenuated neuroinflammation, synapse damage and microglial phagocytosis after hypoxia-ischemia injury by preventing osteopontin expression. Pharmacological Research. 164. 105322–105322. 38 indexed citations
10.
11.
12.
Chu, Xili, Dexiang Liu, Tingting Li, et al.. (2020). Hydrogen sulfide-modified extracellular vesicles from mesenchymal stem cells for treatment of hypoxic-ischemic brain injury. Journal of Controlled Release. 328. 13–27. 38 indexed citations
13.
Liu, Dexiang, Xuemei Bai, Weiwei Ma, et al.. (2020). Purmorphamine Attenuates Neuro-Inflammation and Synaptic Impairments After Hypoxic-Ischemic Injury in Neonatal Mice via Shh Signaling. Frontiers in Pharmacology. 11. 29 indexed citations
14.
Zhou, Xin, Jie Qiu, Danqing Xin, et al.. (2019). <p>Exosomes Derived From Bone Marrow Mesenchymal Stem Cells Inhibit Complement Activation In Rats With Spinal Cord Injury</p>. Drug Design Development and Therapy. Volume 13. 3693–3704. 66 indexed citations
15.
Li, Jiangbing, Hao Xue, Tingting Li, et al.. (2019). Exosomes derived from mesenchymal stem cells attenuate the progression of atherosclerosis in ApoE−/- mice via miR-let7 mediated infiltration and polarization of M2 macrophage. Biochemical and Biophysical Research Communications. 510(4). 565–572. 174 indexed citations
16.
Zhou, Xin, Xili Chu, Danqing Xin, et al.. (2019). L-Cysteine-Derived H2S Promotes Microglia M2 Polarization via Activation of the AMPK Pathway in Hypoxia-Ischemic Neonatal Mice. Frontiers in Molecular Neuroscience. 12. 58–58. 35 indexed citations
17.
Wang, Zhen, Yunkai Xie, Xin Zhou, et al.. (2019). Resveratrol reduces brain injury after subarachnoid hemorrhage by inhibiting oxidative stress and endoplasmic reticulum stress. Neural Regeneration Research. 14(10). 1734–1734. 38 indexed citations
18.
Zhou, Xin, Xili Chu, Hongtao Yuan, et al.. (2019). Mesenchymal stem cell derived EVs mediate neuroprotection after spinal cord injury in rats via the microRNA-21-5p/FasL gene axis. Biomedicine & Pharmacotherapy. 115. 108818–108818. 93 indexed citations
19.
20.
Xin, Danqing, Xili Chu, Xuemei Bai, et al.. (2018). l-Cysteine suppresses hypoxia-ischemia injury in neonatal mice by reducing glial activation, promoting autophagic flux and mediating synaptic modification via H2S formation. Brain Behavior and Immunity. 73. 222–234. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danqing Xin Breakdown of academic impact, for papers by Takeru Hamashima Breakdown of academic impact, for papers by Oneil G. Bhalala Breakdown of academic impact, for papers by Yanjie Jia Breakdown of academic impact, for papers by Kai Gao Breakdown of academic impact, for papers by Xiaoming Che Breakdown of academic impact, for papers by Tanya L. Butler Breakdown of academic impact, for papers by Chengcheng Cui Breakdown of academic impact, for papers by Yuhong Zhu Breakdown of academic impact, for papers by Hsin-I Ma
Rankless by CCL
2026